Credit Suisse Reiterates Neutral Rating, Raises Price Target On CME Group Following Financials Conference

In a report published Wednesday, Credit Suisse analyst Christian Bolu reiterated a Neutral rating on CME Group Inc (NASDAQ: CME), and raised the price target from $90.00 to $95.00.

In the report, Credit Suisse noted, "Marking to market our estimates for quarter-to-date volume trends, we raise our 1Q/2015 estimates to $0.96/$3.71 (old: $0.93/$3.70). Our 2016/2017 estimates are unchanged at $4.10/$4.25. Our revised $95 (old: $90) per share target price implies CME shares are able to trade at 23x our 2016 EPS estimate. We currently rate CME shares at Neutral— while we appreciate CME's diverse product set, best-in-class distribution/clearing platforms and strong free cash flow generation prospects, we see more balanced risk/reward at current valuations."

CME Group closed on Tuesday at $94.20.